Get the latest Science News and Discoveries

NRG Oncology Trial Finds No Difference in NeurocoNRG Oncology trial finds no difference in neurocognitive outcomes, but improved overall survival with stereotactic radiosurgery for SCLC brain metastases

None

Related news:

Personalized programs to prevent falls may make no difference: Cochrane review

Investigational immunotherapy nearly doubles overall survival compared with docetaxel in advanced squamous NSCLC

Phase III ARTEMIS-008 trial shows risvutatug rezetecan significantly improves overall survival in relapsed small-cell lung cancer